Recent Developments in Protein and Cell-Targeted Aptamer Selection and Applications

被引:49
作者
Liu, Jun [1 ,3 ,4 ,5 ]
You, Mingxu [3 ,4 ,5 ]
Pu, Ying [1 ,3 ,4 ,5 ]
Liu, Huixia [1 ]
Ye, Mao [2 ]
Tan, Weihong [2 ,3 ,4 ,5 ]
机构
[1] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
[2] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Coll Biol, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China
[3] Univ Florida, Ctr Res Bio Nano Interface, Dept Chem, Gainesville, FL 32611 USA
[4] Univ Florida, Dept Physiol & Funct Gen, Shands Canc Ctr, UF Genet Inst, Gainesville, FL 32611 USA
[5] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
Aptamer; biomarker discovery; detection; drug delivery; imaging; molecular probe; SELEX; visualization; IN-VITRO SELECTION; CAPILLARY-ELECTROPHORESIS; MOLECULAR RECOGNITION; SYSTEMATIC EVOLUTION; DNA APTAMERS; RNA APTAMERS; CANCER-CELLS; EQUILIBRIUM MIXTURES; AUTOMATED SELECTION; BINDING APTAMER;
D O I
10.2174/092986711797189619
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Because of their easily modified chemical structures and wide range of targets, aptamers are ideal candidates for various applications, such as biomarker discovery, target diagnosis, molecular imaging, and drug delivery. Aptamers are oligonucleotide sequences that can bind to their targets specifically via unique three dimensional (3-D) structures. Usually, aptamers are obtained from repeated rounds of in vitro or in vivo selection termed SELEX (Systematic Evolution of Ligands by EXponential enrichment), which can generate aptamers with high affinity and specificity for many kinds of targets, such as biomedically important proteins and even cancer cells. In this review, some basic principles and recent developments in the design of SELEX process are discussed, hopefully to provide some guidelines towards performing more efficient aptamer isolation procedures. Moreover, the biomedical and bioanalytical applications of aptamers are further reviewed, based on some smart biochemical modifications of these oligonucleotide structures.
引用
收藏
页码:4117 / 4125
页数:9
相关论文
共 105 条
[1]  
Antisoma, 2010, ANT CLIN DEV PIP
[2]  
Archemix, 2009, PROD PIP
[3]  
Archemix and Nuvelo close phase I trial for thrombin inhibitor, 2009, ARC183 ARCH
[4]   Selection and versatile application of virus-specific aptamers [J].
Balogh, Zsofia ;
Lautner, Gergely ;
Bardoczy, Viola ;
Komorowska, Beata ;
Gyurcsanyi, Robert. E. ;
Meszaros, Tamas .
FASEB JOURNAL, 2010, 24 (11) :4187-4195
[5]   Nonequilibrium capillary electrophoresis of equilibrium mixtures: A universal tool for development of aptamers [J].
Berezovski, M ;
Drabovich, A ;
Krylova, SM ;
Musheev, M ;
Okhonin, V ;
Petrov, A ;
Krylov, SN .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (09) :3165-3171
[6]   Aptamer-facilitated biomarker discovery (AptaBiD) [J].
Berezovski, Maxim V. ;
Lechmann, Matthias ;
Musheev, Michael U. ;
Mak, Tak W. ;
Krylov, Sergey N. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (28) :9137-9143
[7]   Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels - Selective targeting of endothelial regulatory protein pigpen [J].
Blank, M ;
Weinschenk, T ;
Priemer, M ;
Schluesener, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :16464-16468
[8]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[9]   Aptamers come of age - at last [J].
Bunka, David H. J. ;
Stockley, Peter G. .
NATURE REVIEWS MICROBIOLOGY, 2006, 4 (08) :588-596
[10]   Direct in vitro selection of a 2′-O-methyl aptamer to VEGF [J].
Burmeister, PE ;
Lewis, SD ;
Silva, RF ;
Preiss, JR ;
Horwitz, LR ;
Pendergrast, PS ;
McCauley, TG ;
Kurz, JC ;
Epstein, DM ;
Wilson, C ;
Keefe, AD .
CHEMISTRY & BIOLOGY, 2005, 12 (01) :25-33